In its appeal from an adverse decision on priority by the Patent Trial and Appeal Board (PTAB) in Interference No. 106,115 (directed to CRISPR-mediated gene editing), Junior Party the.
In Dionex Softron GmbH v. Agilent Technologies, Inc., Nos. 21-1794 and 21-2372, the Court of Appeals for the Federal Circuit ("the Federal Circuit") affirmed interference decisions.
As the dodo of patent practice, the number of interferences has been steadily dwindling since enactment of the Leahy-Smith America Invents Act in 2012 abolished the practice in favor of.
On June 21, 2022, US Patent & Trademark Office (PTO) Director Katherine K. Vidal issued a memorandum addressing interim procedures for discretionary denials in America Invents Act.
US Patent & Trademark Office PTO Director issued a memorandum addressing interim procedures for discretionary denials in America Invents Act AIA-post grant proceedings at the Patent Trial & Appeal Board. The memo clarified the second factor of the Fintiv analysis